A previous study on the effect of AGR2 overexpression on drug resistance also found ADAMTS6 expression to be reduced in NSCLC; however, the experiment did not specify the histological subtype of the studied tumor. This evidence concerns the gene ADAMTS6 and non-small cell lung carcinoma.